Try our Advanced Search for more refined results
PHYSICIANS HEALTHSOURCE, INC. v. JANSSEN PHARMACEUTICALS, INC. et al
Case Number:
3:12-cv-02132
Court:
Nature of Suit:
Judge:
Firms
-
September 03, 2015
J&J Unit Can't Get Judge To Reconsider Bid To Nix TCPA Suit
A New Jersey federal judge said Wednesday she won't reconsider a decision denying Johnson & Johnson unit Janssen Pharmaceuticals judgment in a proposed class action over alleged junk faxes that violate the Telephone Consumer Protection Act, finding that a recent Sixth Circuit opinion doesn't change the law.
-
November 24, 2014
J&J Unit's Junk Faxes Are Ads, Not Info, Plaintiffs Say
Physicians Healthsource Inc. told a New Jersey federal court on Friday it can't dismiss a proposed Telephone Consumer Protection Act class action against Johnson & Johnson unit Janssen Pharmaceuticals Inc. because the alleged junk faxes sent by the pharmaceutical company aren't informational.
-
April 02, 2014
J&J Unit Can't Escape TCPA Junk Fax Suit
A New Jersey federal judge on Wednesday refused to dismiss a putative class action accusing Johnson & Johnson unit Janssen Pharmaceuticals Inc. of sending unsolicited faxes that violated the Telephone Consumer Protection Act, ruling that the plaintiffs still need the opportunity to take discovery.
-
June 06, 2013
TCPA Junk Fax Suit Against J&J Unit Wins 2nd Chance
A federal judge on Thursday offered another chance for a tossed putative class action in New Jersey accusing Johnson & Johnson unit Janssen Pharmaceuticals Inc. of sending unsolicited faxes that violated federal law, allowing the plaintiff to amend its complaint.
-
March 15, 2013
Plaintiff Wants J&J Unit TCPA Junk Fax Suit Reopened
A plaintiff in a tossed class action accusing Johnson & Johnson unit Janssen Pharmaceuticals Inc. of sending unsolicited faxes that violated federal law urged a New Jersey federal judge on Friday to reopen the case, saying the defendants haven't shown why the ruling should stand.
-
February 01, 2013
J&J Unit Beats TCPA Junk Fax Class Action
A New Jersey federal judge on Thursday tossed a proposed class action alleging Johnson & Johnson unit Janssen Pharmaceuticals Inc. and its marketing company violated the Telephone Consumer Protection Act, agreeing that unsolicited faxes they sent medical practices were not advertisements.